7859
ALMEDIO INC.
アルメディオ
- Industry
- Other Products
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
2,681,463
Mar 2022
3,266,337
Mar 2023
4,940,625
Mar 2024
11,557,357
Mar 2025
5,800,748
Operating profit(thousand JPY)
Mar 2021
-11,321
Mar 2022
74,670
Mar 2023
535,567
Mar 2024
3,364,276
Mar 2025
867,137
Operating profit margin(%)
Mar 2021
-0.42
Mar 2022
2.29
Mar 2023
10.84
Mar 2024
29.11
Mar 2025
14.95
Profit before tax(thousand JPY)
Mar 2021
-86,667
Mar 2022
31,676
Mar 2023
417,169
Mar 2024
3,277,999
Mar 2025
806,171
Profit(thousand JPY)
Mar 2021
-135,765
Mar 2022
-39,789
Mar 2023
164,064
Mar 2024
2,328,595
Mar 2025
476,399
Total assets(thousand JPY)
Mar 2021
3,475,103
Mar 2022
4,349,184
Mar 2023
5,809,890
Mar 2024
9,756,423
Mar 2025
9,689,598
Cash and cash equivalents(thousand JPY)
Mar 2021
1,397,986
Mar 2022
1,388,323
Mar 2023
1,257,870
Mar 2024
3,683,128
Mar 2025
3,841,962
Cash flows from operating activities(thousand JPY)
Mar 2021
45,216
Mar 2022
-280,717
Mar 2023
447,850
Mar 2024
2,249,768
Mar 2025
866,454
Cash flows from investing activities(thousand JPY)
Mar 2021
-135,263
Mar 2022
-347,057
Mar 2023
-1,049,049
Mar 2024
-1,283,059
Mar 2025
-698,720
Cash flows from financing activities(thousand JPY)
Mar 2021
-41,008
Mar 2022
547,895
Mar 2023
439,005
Mar 2024
1,403,146
Mar 2025
-76,711
Return on equity(%)
Mar 2021
-5.3
Mar 2022
-1.5
Mar 2023
5.4
Mar 2024
42.6
Mar 2025
6
Equity ratio(%)
Mar 2021
71.7
Mar 2022
62.7
Mar 2023
58.2
Mar 2024
77.4
Mar 2025
84.7
Earnings per share(JPY per share)
Mar 2021
-9.24
Mar 2022
-2.65
Mar 2023
9.17
Mar 2024
123.44
Mar 2025
23.07
Net assets per share(JPY per share)
Mar 2021
169.7
Mar 2022
174.14
Mar 2023
182.41
Mar 2024
364.86
Mar 2025
409.59
Dividend per share(JPY per share)
Mar 2021
0
Mar 2022
0
Mar 2023
0
Mar 2024
0
Mar 2025
0
Payout ratio(%)
Mar 2021
-
Mar 2022
-
Mar 2023
0
Mar 2024
0
Mar 2025
0
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.